Cargando…

Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy

Diabetic cardiomyopathy (DCM), a main cardiovascular complication of diabetes, can eventually develop into heart failure and affect the prognosis of patients. Myocardial fibrosis is the main factor causing ventricular wall stiffness and heart failure in DCM. Early control of myocardial fibrosis in D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yanan, Wang, Yan, Yin, Ruili, Xu, Yongsong, Zhang, Lijie, Zhang, Yuanyuan, Yang, Longyan, Zhao, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102655/ https://www.ncbi.nlm.nih.gov/pubmed/37065745 http://dx.doi.org/10.3389/fendo.2023.1162754

Ejemplares similares

Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
por: Mao, Lin, et al.
Publicado: (2022)

Myocardial protection of S-nitroso-L-cysteine in diabetic cardiomyopathy mice
por: Peng, Lulu, et al.
Publicado: (2022)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
por: Kanasaki, Keizo, et al.
Publicado: (2013)

Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment
por: Yin, Ruili, et al.
Publicado: (2022)

Dynamic changes in cardiac morphology, function, and diffuse myocardial fibrosis duration of diabetes in type 1 and type 2 diabetic mice models using 7.0 T CMR and echocardiography
por: Zhang, Hong-Kai, et al.
Publicado: (2023)

Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy
por: Du, Shuqin, et al.
Publicado: (2022)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts
por: Schlittler, Maja, et al.
Publicado: (2023)

SGLT2 inhibition restrains thyroid cancer growth via G1/S phase transition arrest and apoptosis mediated by DNA damage response signaling pathways
por: Wang, Yan, et al.
Publicado: (2022)

Senescent Cardiac Fibroblast Is Critical for Cardiac Fibrosis after Myocardial Infarction
por: Zhu, Fuli, et al.
Publicado: (2013)

Physical Exercise and Its Protective Effects on Diabetic Cardiomyopathy: What Is the Evidence?
por: Zheng, Jia, et al.
Publicado: (2018)

Diabetic Cardiomyopathy: An Immunometabolic Perspective
por: Mishra, Paras K., et al.
Publicado: (2017)

Endothelial Dysfunction and Diabetic Cardiomyopathy
por: Wang, Moran, et al.
Publicado: (2022)

Association Between Echocardiographic Non-invasive Myocardial Work Indices and Myocardial Fibrosis in Patients With Dilated Cardiomyopathy
por: Cui, Cunying, et al.
Publicado: (2021)

Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy
por: Peng, Meng-ling, et al.
Publicado: (2022)

Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy
por: Ke, Xiangyu, et al.
Publicado: (2021)

Diabetic cardiomyopathy: Clinical phenotype and practice
por: Zhao, Xudong, et al.
Publicado: (2022)

Epigenetics of methylation modifications in diabetic cardiomyopathy
por: Hao, Jing, et al.
Publicado: (2023)

Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis
por: Amrute, Junedh M., et al.
Publicado: (2023)

Fibroblast Growth Factor 19 in Gestational Diabetes Mellitus and Fetal Growth
por: Yang, Meng-Nan, et al.
Publicado: (2022)

Ferroptosis: roles and molecular mechanisms in diabetic cardiomyopathy
por: Zhao, Yangting, et al.
Publicado: (2023)

T(1) mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy
por: Liu, Ying, et al.
Publicado: (2016)

Risk of cardiac rupture among elderly patients with diabetes presenting with first acute myocardial infarction
por: Zu, Xiaolin, et al.
Publicado: (2023)

Yes-Associated Protein is Involved in Myocardial Fibrosis in Rats with Diabetic Cardiomyopathy
por: Hu, Maomao, et al.
Publicado: (2021)

CMR-Verified Myocardial Fibrosis Is Associated With Subclinical Diastolic Dysfunction in Primary Aldosteronism Patients
por: Zhou, Fangli, et al.
Publicado: (2021)

Adropin Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study
por: Liu, Mao, et al.
Publicado: (2021)

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
por: He, Yi, et al.
Publicado: (2010)

Cystic Fibrosis-Related Diabetes
por: Kayani, Kayani, et al.
Publicado: (2018)

Effects of Direct Renin Inhibition on Myocardial Fibrosis and Cardiac Fibroblast Function
por: Zhi, Hui, et al.
Publicado: (2013)

Calcineurin/NFATc3 pathway mediates myocardial fibrosis in diabetes by impairing enhancer of zeste homolog 2 of cardiac fibroblasts
por: Zhang, Lei, et al.
Publicado: (2023)

Glycolysis Inhibition Alleviates Cardiac Fibrosis After Myocardial Infarction by Suppressing Cardiac Fibroblast Activation
por: Chen, Zhi-Teng, et al.
Publicado: (2021)

Chronic O-GlcNAcylation and Diabetic Cardiomyopathy: The Bitterness of Glucose
por: Ducheix, Simon, et al.
Publicado: (2018)

Spermine Regulates Immune and Signal Transduction Dysfunction in Diabetic Cardiomyopathy
por: Wei, Can, et al.
Publicado: (2022)

Phloretin Prevents Diabetic Cardiomyopathy by Dissociating Keap1/Nrf2 Complex and Inhibiting Oxidative Stress
por: Ying, Yin, et al.
Publicado: (2018)

Cardiac Fibroblasts and Myocardial Regeneration
por: Chen, Wangping, et al.
Publicado: (2021)

Integrated bioinformatic analysis reveals immune molecular markers and potential drugs for diabetic cardiomyopathy
por: Guo, Qixin, et al.
Publicado: (2022)

Cardiac Fibrosis and Fibroblasts
por: Kurose, Hitoshi
Publicado: (2021)

Circulating Angptl3 and Angptl8 Are Increased in Patients with Hypothyroidism
por: Yang, Longyan, et al.
Publicado: (2019)

Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21–AMPK pathway in mice fed a high fat diet
por: Zhang, Yuanyuan, et al.
Publicado: (2022)

Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAs
por: Macvanin, Mirjana T., et al.
Publicado: (2023)

NOX1 promotes myocardial fibrosis and cardiac dysfunction via activating the TLR2/NF-κB pathway in diabetic cardiomyopathy
por: Zhang, Dandan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t7mfjgur7ehb9i7lh50m6h90d1